The content of this website is intended for United States audiences only.
LAST UPDATED
February 06 2025
Clinicaltrials.gov ID
EudraCT ID
CTSID
CTSID
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
The goal of this clinical study is to learn more about the long-term safety, effectiveness and prolonged action of Kite study drugs, axicabtagene ciloleucel, brexucabtagene autoleucel, KITE-363, KITE-753, KITE-197, and anitocabtagene autoleucel in participants of Kite-sponsored interventional studies.
View MoreAge
N/A
Sex
ALL
Healthy Volunteers
No
Medical Condition
Solid and Hematological Malignancies
Gender
N/A
Date
December 2021 - December 2040
Study Type
OBSERVATIONAL
Study Phase
Product
Axicabtagene Ciloleucel, Brexucabtagene Autoleucel, Anitocabtagene autleucel, KITE-753, KITE-197, KITE-363
Gilbert, Arizona, United States, 85234
Duarte, California, United States, 91010
La Jolla, California, United States, 92093
Los Angeles, California, United States, 90027
Los Angeles, California, United States, 90095
Orange, California, United States, 92868
Palo Alto, California, United States, 94305
Sacramento, California, United States, 95817
San Francisco, California, United States, 94143
Denver, Colorado, United States, 80218
Washington, District of Columbia, United States, 20007
Miami, Florida, United States, 33136
Tampa, Florida, United States, 33612
Chicago, Illinois, United States, 60611
Chicago, Illinois, United States, 60637
Maywood, Illinois, United States, 60153
Iowa City, Iowa, United States, 52242
Westwood, Kansas, United States, 66205
Baltimore, Maryland, United States, 21201
Boston, Massachusetts, United States, 02215
Detroit, Michigan, United States, 48201
Saint Louis, Missouri, United States, 63110
Omaha, Nebraska, United States, 68198
Hackensack, New Jersey, United States, 07601
Bronx, New York, United States, 10467
Buffalo, New York, United States, 14263
New York, New York, United States, 10029
New York, New York, United States, 10032
New York, New York, United States, 10065
Rochester, New York, United States, 14642
Rochester, New York, United States, 55905
Durham, North Carolina, United States, 27710
Cleveland, Ohio, United States, 44195
Columbus, Ohio, United States, 43220
Philadelphia, Pennsylvania, United States, 19104
Philadelphia, Pennsylvania, United States, 19111
Pittsburgh, Pennsylvania, United States, 15232
Nashville, Tennessee, United States, 37203
Nashville, Tennessee, United States, 37232
Dallas, Texas, United States, 75246
Houston, Texas, United States, 77030
Seattle, Washington, United States, 98104
Seattle, Washington, United States, 98109
Melbourne, Victoria, Australia, 3000
Innsbruck, Austria, 6020
Leuven, Belgium, 3000
Montreal, Canada, H4A 3J1
Ottawa, Canada, K1YE9
Quebec, Canada, G1J 1Z4
Toronto, Canada, M5G 1X8
Toronto, Canada, M5G 2C4
Vancouver, Canada, V5Z 1M9
Lille, France, 59037
Montpellier CEDEX 05, France, 34295
Paris, France, 75010
Pessac, France, 33604
Pierre Benite, France, 69495
Rennes, France, 35033
Dresden, Germany, 01307
Hamburg, Germany, 20246
Heidelberg, Germany, 69120
Mainz, Germany, 55101
München, Germany, 81377
Wuerzburg, Germany, 97080
Tel Aviv, Israel, 6423906
Milano, Italy, 20162
Fukuoka, Japan, 812-8582
Kyoto, Japan, 606-8507
Okayama, Japan, 700-8558
Sapporo Hokkaido, Japan, 060-8648
Tokyo, Japan, 104-0045
Amsterdam, Netherlands, 1100
Groningen, Netherlands, 9700 RB
Nijmegen, Netherlands, 6525 GA
Rotterdam, Netherlands, 3011PL
Utrecht, Netherlands, 3508 GA
Barcelona, Spain, 08036
Barcelona, Spain, 08908
Salamanca, Spain, 37007
Bellinzona, Switzerland, 6500
London, United Kingdom, SW10 9NH
Share Trial